| α-Emitters for radiotherapy: From basic radiochemistry to clinical studies—Part 1 S Poty, LC Francesconi, MR McDevitt, MJ Morris, JS Lewis Journal of Nuclear Medicine 59 (6), 878-884, 2018 | 197 | 2018 |
| α-Emitters for radiotherapy: from basic radiochemistry to clinical studies—part 2 S Poty, LC Francesconi, MR McDevitt, MJ Morris, JS Lewis Journal of Nuclear Medicine 59 (7), 1020-1027, 2018 | 89 | 2018 |
| Leveraging bioorthogonal click chemistry to improve 225Ac-radioimmunotherapy of pancreatic ductal adenocarcinoma S Poty, LM Carter, K Mandleywala, R Membreno, D Abdel-Atti, ... Clinical Cancer Research 25 (2), 868-880, 2019 | 73 | 2019 |
| Innovative magnetic nanoparticles for PET/MRI bimodal imaging G Thomas, J Boudon, L Maurizi, M Moreau, P Walker, I Severin, A Oudot, ... ACS omega 4 (2), 2637-2648, 2019 | 57 | 2019 |
| A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals SK Sharma, SK Lyashchenko, HA Park, N Pillarsetty, Y Roux, J Wu, ... Nuclear medicine and biology 71, 32-38, 2019 | 55 | 2019 |
| The inverse electron-demand Diels–Alder reaction as a new methodology for the synthesis of 225 Ac-labelled radioimmunoconjugates S Poty, R Membreno, JM Glaser, A Ragupathi, WW Scholz, BM Zeglis, ... Chemical Communications 54 (21), 2599-2602, 2018 | 39 | 2018 |
| New AMD3100 derivatives for CXCR4 chemokine receptor targeted molecular imaging studies: synthesis, anti-HIV-1 evaluation and binding affinities S Poty, P Désogère, C Goze, F Boschetti, D Schols, C Cawthorne, ... Dalton transactions 44 (11), 5004-5016, 2015 | 37 | 2015 |
| Preclinical optimization of antibody‐based radiopharmaceuticals for cancer imaging and radionuclide therapy—Model, vector, and radionuclide selection LM Carter, S Poty, SK Sharma, JS Lewis Journal of Labelled Compounds and Radiopharmaceuticals 61 (9), 611-635, 2018 | 34 | 2018 |
| Trastuzumab gold-conjugates: Synthetic approach and in vitro evaluation of anticancer activities in breast cancer cell lines N Curado, G Dewaele-Le Roi, S Poty, JS Lewis, M Contel Chemical Communications 55 (10), 1394-1397, 2019 | 31 | 2019 |
| AMD3100: A Versatile Platform for CXCR4 Targeting 68Ga-Based Radiopharmaceuticals S Poty, E Gourni, P Désogère, F Boschetti, C Goze, HR Maecke, F Denat Bioconjugate Chemistry 27 (3), 752-761, 2016 | 31 | 2016 |
| From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy: The Montpellier group's experience JP Pouget, L Santoro, B Piron, S Paillas, R Ladjohounlou, A Pichard, ... Nuclear Medicine and Biology, 2021 | 22 | 2021 |
| Therapeutic antibodies–natural and pathological barriers and strategies to overcome them Y Al Ojaimi, T Blin, J Lamamy, M Gracia, A Pitiot, C Denevault-Sabourin, ... Pharmacology & therapeutics, 108022, 2021 | 20 | 2021 |
| Efficient Synthesis of 1, 4, 7‐Triazacyclononane and 1, 4, 7‐Triazacyclononane‐Based Bifunctional Chelators for Bioconjugation P Désogère, Y Rousselin, S Poty, C Bernhard, C Goze, F Boschetti, ... European Journal of Organic Chemistry 2014 (35), 7831-7838, 2014 | 20 | 2014 |
| Targeted Radionuclide Therapy Using Auger Electron Emitters: The Quest for the Right Vector and the Right Radionuclide MB Idrissou, A Pichard, B Tee, T Kibedi, S Poty, JP Pouget Pharmaceutics 13 (7), 980, 2021 | 18 | 2021 |
| 89Zr-PET imaging of DNA double-strand breaks for the early monitoring of response following α-and β-particle radioimmunotherapy in a mouse model of pancreatic ductal adenocarcinoma S Poty, K Mandleywala, E O'Neill, JC Knight, B Cornelissen, JS Lewis Theranostics 10 (13), 5802, 2020 | 18 | 2020 |
| MANOTA: a promising bifunctional chelating agent for copper-64 immunoPET M Moreau, S Poty, JM Vrigneaud, P Walker, M Guillemin, O Raguin, ... Dalton Transactions 46 (42), 14659-14668, 2017 | 14 | 2017 |
| MA‐NOTMP: A Triazacyclononane Trimethylphosphinate Based Bifunctional Chelator for Gallium Radiolabelling of Biomolecules S Poty, P Désogère, J Šimeček, C Bernhard, V Goncalves, C Goze, ... ChemMedChem 10 (9), 1475-1479, 2015 | 11 | 2015 |
| Identification of new FK866 analogues with potent anticancer activity against pancreatic cancer JF Bai, SR Majjigapu, B Sordat, S Poty, P Vogel, P Elías-Rodriguez, ... European Journal of Medicinal Chemistry, 114504, 2022 | 7 | 2022 |
| In vivo validation of 68Ga-labeled AMD3100 conjugates for PET imaging of CXCR4 I Renard, J Domarkas, S Poty, BP Burke, DP Roberts, C Goze, F Denat, ... Nuclear Medicine and Biology, 108335, 2023 | 4 | 2023 |
| Antibody-drug conjugates based on gold compounds M Contel, N Curado, J Lewis, S Poty US Patent App. 16/503,958, 2020 | 3 | 2020 |
